Cargando…
Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
Autores principales: | Arashiro, Takeshi, Arima, Yuzo, Kuramochi, Jin, Muraoka, Hirokazu, Sato, Akihiro, Chubachi, Kumi, Oba, Kunihiro, Yanai, Atsushi, Arioka, Hiroko, Uehara, Yuki, Ihara, Genei, Kato, Yasuyuki, Yanagisawa, Naoki, Nagura, Yoshito, Yanai, Hideki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Oka, Hideaki, Nishida, Yusuke, Ooki, Takao, Nidaira, Yuki, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881180/ https://www.ncbi.nlm.nih.gov/pubmed/36700869 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.4.2300034 |
Ejemplares similares
-
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)
por: Arashiro, Takeshi, et al.
Publicado: (2022) -
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
por: Arashiro, Takeshi, et al.
Publicado: (2023) -
Behavioral factors associated with SARS‐CoV‐2 infection in Japan
por: Arashiro, Takeshi, et al.
Publicado: (2022) -
Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan
por: Arashiro, Takeshi, et al.
Publicado: (2022) -
A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity
por: Moriyama, Yuki, et al.
Publicado: (2022)